Some studies show no change in GSH status upon supplementation of oral glutathione (reduced form) in healthy subjects
A., Dunn, J., Haupt, A., Milicevic, Z., & Coskun, T
Data from cardiovascular outcomes trials suggest that GLP-1 agonists provide cardioprotective effects independent of weight loss, including reduced myocardial infarction rates and improved heart failure outcomes
To make sure you're getting the best possible start you can, make sure you're getting your compounded semaglutide from a reputable source
For people tracking their semaglutide results week by week , consistently hitting protein targets through meals like this is what separates dramatic results from mediocre ones
Obes Res Clin Pract 19:6369 Jastreboff AM, Kaplan LM, Fras JP et al (2023) Triple-hormone-receptor agonist Retatrutide for obesity - a phase 2 trial